FIBROGEN, INC. FGEN Balance Sheet

Fibrogen, inc. (FGEN)

Balance Sheet / Yearly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14
Assets
Current assets:
Cash and cash equivalents
121,560	126,266	196,592	74,587	81,673	89,258	566,722	643,803	659,007	673,658	651,373	290,277	170,598	173,782	198,283	190,411	140,959	153,324	208,650	236,536	128,369	165,455
Short-term investments
413,869	407,491	432,040	586,174	483,726	532,144	86,009	28,094	44,761	62,060	78,599	69,121	72,824	79,397	43,522	40,105	32,454	27,847	12,873	12,129	14,322	14,364
Accounts receivable, net ($3,723 and $4,845 from a related party)
58,540	28,455	19,225	6,453	6,023	63,684	23,187	30,189	9,975	8,452	8,628	8,933	7,248	10,448	7,692	18,088	5,937	15,405	7,373	12,183	6,963	13,453
Inventories
8,408	6,887	4,908	1,981	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses and other current assets ($126,558 and $125,210 from a related party)
134,028	133,391	133,715	136,596	7,578	4,929	2,865	17,997	3,420	4,800	2,856	3,013	5,911	2,889	3,965	3,705	4,651	3,988	3,677	2,731	5,746	4,966
Total current assets
736,405	702,490	786,480	805,791	579,000	690,015	678,783	720,083	717,163	748,970	741,456	371,344	256,581	266,516	253,462	252,309	184,001	200,564	232,573	263,579	155,400	198,238
Restricted time deposits
2,072	2,072	4,145	4,145	4,145	4,100	5,181	5,181	5,181	5,181	6,217	6,217	6,217	6,217	7,254	7,254	7,254	7,254	7,254	7,254	7,254	7,254
Long-term investments
223	61,118	10,999	10,915	132,203	55,820	40,602	10,587	10,506	10,506	16,767	39,204	53,155	71,010	98,730	111,540	122,009	131,720	127,974	138,310	139,518	144,269
Property and equipment, net
40,058	42,743	43,208	44,865	45,828	127,198	127,908	128,829	129,880	129,476	126,643	122,591	122,818	123,657	124,774	126,264	127,613	129,020	129,607	130,451	131,660	132,171
Finance lease right-of-use assets
37,017	39,602	42,064	44,536	47,029	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
8,602	9,372	7,068	4,814	4,192	3,420	3,167	5,239	4,881	4,517	3,809	3,282	2,985	2,152	1,993	1,762	1,658	2,016	1,839	1,801	1,708	1,596
Total assets
824,377	857,397	893,964	915,066	812,397	880,598	855,641	869,919	867,611	898,650	894,892	542,638	441,756	469,552	486,213	499,129	442,535	470,574	499,247	541,395	435,540	483,528
Liabilities, stockholders’ equity and non-controlling interests
Current liabilities:
Accounts payable
2,865	6,088	4,055	4,060	3,772	9,139	10,131	3,222	3,549	5,509	6,407	3,261	2,950	6,223	2,039	3,474	1,543	6,521	4,234	3,915	2,433	4,551
Accrued and other current liabilities ($92 and $36,883 to a related party)
42,309	83,816	70,825	66,545	66,278	66,123	52,598	49,492	62,859	63,781	54,117	48,534	49,179	50,914	51,748	47,942	44,038	47,932	41,774	46,240	42,466	48,985
Deferred revenue
8,531	490	257	136	12,104	13,771	37,697	37,845	16,934	16,670	7,974	7,979	7,984	7,988	7,957	15,027	12,722	12,728	12,980	13,347	9,058	9,218
Finance lease liabilities, current
12,396	12,351	12,149	12,071	11,766	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total current liabilities
66,101	102,745	87,286	82,812	93,920	89,033	100,426	90,559	83,342	85,960	68,498	59,774	60,113	65,125	61,744	66,443	58,303	67,181	58,988	63,502	53,957	62,754
Long-term portion of lease obligations
1,040	1,141	1,242	1,342	1,443	97,157	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product development obligations
16,536	16,780	16,256	16,846	16,545	16,798	16,948	16,981	17,824	17,244	16,922	16,284	15,152	14,854	15,744	15,515	15,786	15,085	15,433	15,186	14,774	16,465
Deferred rent
-	-	0	0	0	3,038	3,197	3,350	3,503	3,657	3,799	3,936	4,075	4,212	4,339	4,461	4,581	4,702	4,814	4,917	5,024	5,131
Deferred revenue, net of current
139,404	99,449	98,708	102,926	135,196	136,109	136,874	137,436	137,972	138,241	110,844	109,579	108,068	106,709	104,636	97,947	85,328	85,132	85,720	87,273	60,326	60,988
Finance lease liabilities, non-current
34,545	37,610	40,713	43,780	46,818	0	97,323	97,473	97,620	97,763	97,370	97,451	97,536	97,352	97,377	97,395	97,077	97,042	96,990	96,929	96,873	96,818
Other long-term liabilities
89,122	64,266	36,041	19,058	9,981	9,993	10,291	9,318	8,561	8,047	6,690	6,245	5,840	6,191	4,757	4,991	5,237	4,607	747	702	699	696
Total liabilities
346,748	321,991	280,246	266,764	303,903	352,128	365,059	355,117	348,822	350,912	304,123	293,269	290,784	294,443	288,597	286,752	266,312	273,749	262,692	268,509	231,653	242,852
Commitments and Contingencies
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders’ equity:
Preferred stock, $0.01 par value; 125,000 shares authorized; no shares issued and outstanding at March 31, 2020 and December 31, 2019
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common stock, $0.01 par value; 225,000 shares authorized at March 31, 2020 and December 31, 2019; 88,896 and 87,657 shares issued and outstanding at March 31, 2020 and December 31, 2019
889	877	872	868	861	854	848	842	834	825	818	710	644	637	631	627	624	620	612	604	593	590
Stockholders' notes receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Additional paid-in capital
1,319,354	1,300,725	1,280,396	1,265,783	1,242,460	1,226,453	1,209,813	1,191,524	1,173,109	1,160,094	1,146,112	766,861	634,980	625,903	614,787	605,089	593,935	586,647	574,979	565,229	553,411	546,247
Accumulated other comprehensive income (loss)
1,183	-747	-224	-462	-937	-2,281	-2,570	-2,611	-3,622	-1,795	-1,609	-1,387	-1,020	-960	-1,333	-1,024	-1,704	-1,651	-1,614	-623	-738	-3,149
Accumulated deficit
-863,068	-784,720	-686,597	-637,158	-753,161	-715,827	-736,780	-694,224	-670,803	-630,657	-573,823	-536,086	-502,903	-469,742	-435,740	-411,586	-435,903	-408,062	-356,693	-311,595	-368,650	-322,283
Total stockholders’ equity
458,358	516,135	594,447	629,031	489,223	509,199	471,311	495,531	499,518	528,467	571,498	230,098	131,701	155,838	178,345	193,106	156,952	177,554	217,284	253,615	184,616	221,405
Non-controlling interests
19,271	19,271	19,271	19,271	19,271	19,271	19,271	19,271	19,271	19,271	19,271	19,271	19,271	19,271	19,271	19,271	19,271	19,271	19,271	19,271	19,271	19,271
Total equity
477,629	535,406	613,718	648,302	508,494	528,470	490,582	514,802	518,789	547,738	590,769	249,369	150,972	175,109	197,616	212,377	176,223	196,825	236,555	272,886	203,887	240,676
Total liabilities, stockholders’ equity and non-controlling interests
824,377	857,397	893,964	915,066	812,397	880,598	855,641	869,919	867,611	898,650	894,892	542,638	441,756	469,552	486,213	499,129	442,535	470,574	499,247	541,395	435,540	483,528